PARA BIO OPT NOV24PARA BIO OPT NOV24PARA BIO OPT NOV24

PARA BIO OPT NOV24

No trades
See on Supercharts

Key stats

Market capitalization
‪82.34 M‬AUD
Dividend yield (indicated)
Price to earnings Ratio (TTM)
Basic EPS (TTM)
Net income (FY)
Revenue (FY)
Shares float
Beta (1Y)
4.44

About PARADIGM BIOPHARMACEUTICALS LIMITED..

CEO
Paul John Rennie
Headquarters
Melbourne
Founded
2014
ISIN
AU0000302911
FIGI
BBG01JZ3DX14
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.